Navigation Links
SuperGen Reports 2007 Fourth Quarter and Annual Financial Results
Date:3/3/2008

>

Ended Ended

December 31, December 31,

2007 2006 2007 2006

(Unaudited) (Unaudited)

Revenues:

Net product revenue $- $467 $621 $9,563

Development and license revenue

from MGI PHARMA - 29 - 25,093

Royalty revenue 7,797 2,384 22,333 3,427

Total revenues 7,797 2,880 22,954 38,083

Costs and operating expenses:

Cost of product revenue - 126 221 2,003

Research and development 6,237 5,035 23,423 16,544

Selling, general, and

administrative 3,175 5,402 13,520 24,714

Acquired in-process research and

development - - 9,967 16,318

Gain on sale of products (6,000) - (33,677) -

Total costs and operating expenses 3,412 10,563 13,454 59,579

Income (loss) from operations 4,385 (7,683) 9,500 (21,496)

Interest income 990 952 4,017 2,746

Gain on disposition of investment

in AVI BioPharma stock

resulting from exercise of warrant - - - 780

Other income (expense) (59) 241 (25) 241

Change in valuation of derivatives - 490 - 1,817

Income (loss) before income tax

provision 5,316 (6,000) 13,492 (15,912)

Income tax provision (175) (323) (411) (575)

Net income (loss) $5,141 $(6,323) $13,081 $(
'/>"/>

SOURCE SuperGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. SuperGen to Announce 2007 Fourth Quarter and Fiscal Year-End Financial Results March 3, 2008
2. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
3. Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
4. Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results
5. Genetic Engineering & Biotechnology News reports on advances in miRNA
6. Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results
7. Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
8. Cepheid Reports Fourth Quarter and Full Year 2007 Results
9. Strategic Diagnostics Reports Fourth Quarter and Full-Year Financial Results
10. US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results
11. Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 Per Share for the Fourth Quarter; Adjusted Earnings Were $3.16 Per Share for 2007 and $0.79 Per Share for the Fourth Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Two champions of science, technology, engineering, and mathematics ... competition for middle and high school students designed to ... The competition presents students with real-world problems experienced by ... and Sciences is a program administered by the ...
(Date:1/15/2014)... DTS Language Services, Inc . is pleased ... Life Science organizations who need document translations. Clients will ... their documents in advance with a selection of nearly 50 ... often a critical factor in clinical and scientific fields, and ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... throughput research solutions, today announced that Lupin Limited, one ... of Freeslate’s CM Protégé PharmD System for ... in Mumbai, India, is focused on a wide range ...
(Date:1/15/2014)... , Jan. 15, 2014 TaiGen Biotechnology Company, Limited ... agreement with R-Pharm, a leading Russian pharmaceutical company, to ... Russian Federation , Turkey ... States (CIS). Nemonoxacin is a novel antibiotic for the treatment ...
Breaking Biology Technology:Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5DTS Improves Efficiency for Life Science Document Translations 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... last several months, Ive been using Skype , voice ... lets me make peer-to-peer voice calls from my computer to ... product wasnt purely theoretical. Certainly I wanted to evaluate the ... reason to download and try Skype was a soaring international ...
... in which George Bush and Bill Clinton urge Americans to come ... appeal comes from two former presidents, but because of how they ... , ,Bush and Clinton point viewers to the Web site ... the millions of dollars that have streamed in over the Internet ...
... Automotive supplier Johnson Controls unveiled its newest ... Auto Show in Detroit. The additions to the line ... their existing technology, increasing ease of use for customers ... a growing market, Johnson showed off its latest vehicular ...
Cached Biology Technology:VoIP breaks out, but let's hope it doesn't become a verb 2VoIP breaks out, but let's hope it doesn't become a verb 3Outpouring of tsunami relief displays power of the Internet 2Outpouring of tsunami relief displays power of the Internet 3
(Date:7/9/2014)... Emerging fungal pathogens pose a greater threat to ... declines of amphibians, bats, corals, bees and snakes. ... published in the prestigious journal Nature ... resistance to a deadly chytrid fungus implicated in ... is important because it is the basis of ...
(Date:7/9/2014)... July 9, 2014Biofuels derived from the oils produced by ... fuels. To achieve this goal, optimization of cost effective ... pond systems, is needed. Sapphire Energy has developed an ... pond algae cultivation systems, described in Industrial Biotechnology ... publishers. The article is available on the Industrial ...
(Date:7/9/2014)... Cancer Genome Atlas (TCGA) Research Network have identified ... lung adenocarcinoma, the most common subtype of lung ... the number of possible therapeutic targets for this ... patients with treatable mutations because many potent cancer ... TCGA is jointly funded and managed by the ...
Breaking Biology News(10 mins):USF study: Amphibians can acquire resistance to deadly fungus 2Controlling contamination in open algae ponds for biofuels 2Study identifies novel genomic changes in the most common type of lung cancer 2Study identifies novel genomic changes in the most common type of lung cancer 3
... structure of an essential part of Mediator, a complex molecular ... of DNA. The research adds an important link to ... of how cells translate genetic information into the proteins and ... advance online issue of the journal Nature , were ...
... A genome-wide study by researchers at the RIKEN ... General Hospital has identified a genetic variant associated with ... virus carriers. The findings are based on a study ... Nature Genetics . Hepatocellular carcinoma (HCC), the ...
... University of London have discovered a new way of ... way for furthering our understanding of diseases like type ... will be announced today (3 July) at the Sixth ... Zinc is found throughout the body and involved ...
Cached Biology News:Researchers decipher protein structure of key molecule in DNA transcription system 2Zinc and the zebrafish 2